Tim Friede

Q: What Schools Are Affiliated With Tim Friede

Tim Friede is affiliated with the following schools: University of California, Berkeley, University of Göttingen, Lancaster University, Stanford University, Heidelberg University

Tim Friede's AcademicInfluence.com Rankings

Tim Friede

Computer Science

#8033

World Rank

#8452

Historical Rank

Computational Linguistics

#1721

World Rank

#1739

Historical Rank

Machine Learning

#3174

World Rank

#3213

Historical Rank

Artificial Intelligence

#3477

World Rank

#3527

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Tim Friede's Degrees

PhD Computer Science Stanford University
Masters Computer Science Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Tim Friede Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tim Friede's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis (2005) (613)
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): Validated for teenage school students in England and Scotland. A mixed methods assessment (2011) (329)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) (280)
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. (2012) (249)
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial (2018) (239)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. (2019) (238)
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. (2022) (175)
Sample Size Recalculation in Internal Pilot Study Designs: A Review (2006) (173)
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort (2013) (147)
Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies (2015) (146)
Effect and Feasibility of Controlled Rewarming After Moderate Hypothermia in Stroke Patients With Malignant Infarction of the Middle Cerebral Artery (2001) (135)
Telephone peer-delivered intervention for diabetes motivation and support: the telecare exploratory RCT. (2009) (134)
Re-calculating the sample size in internal pilot study designs with control of the type I error rate. (2000) (129)
Meta‐analysis of few small studies in orphan diseases (2016) (128)
Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. (2017) (126)
Simple procedures for blinded sample size adjustment that do not affect the type I error rate (2003) (110)
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response (2017) (110)
Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. (2005) (107)
Monitoring of 30 marker candidates in early Parkinson disease as progression markers (2016) (103)
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa) (2018) (101)
Methods for evidence synthesis in the case of very few studies (2018) (99)
Pilot of “Families for Health”: community-based family intervention for obesity (2008) (98)
A conditional error function approach for subgroup selection in adaptive clinical trials (2012) (98)
A group‐sequential design for clinical trials with treatment selection (2008) (95)
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review (2016) (94)
Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study (2019) (91)
Cross cultural evaluation of the Warwick-Edinburgh mental well-being scale (WEMWBS) -a mixed methods study (2013) (90)
Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases (2016) (88)
Clinical presentation of pediatric multiple sclerosis before puberty (2014) (85)
Reclassifying Acute Respiratory Distress Syndrome (2018) (81)
A comparison of methods for adaptive sample size adjustment (2001) (80)
Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry (2018) (79)
Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies (2018) (70)
Results of medial patellofemoral ligament reconstruction compared with trochleoplasty plus individual extensor apparatus balancing in patellar instability caused by severe trochlear dysplasia: a systematic review and meta-analysis (2017) (70)
Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: An application in multiple sclerosis (2011) (70)
Sources of Information and Behavioral Patterns in Online Health Forums: Observational Study (2014) (69)
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. (2021) (68)
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. (2016) (65)
Impact of COVID-19 outbreak on regional STEMI care in Germany (2020) (64)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome. (2020) (64)
Multiple sclerosis registries in Europe – results of a systematic survey (2014) (62)
Anticholinergics for urinary symptoms in multiple sclerosis. (2015) (62)
Doxycycline in early CJD: a double-blinded randomised phase II and observational study (2016) (61)
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study (2020) (61)
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients (2012) (61)
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study (2020) (61)
Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection (2014) (57)
Blinded sample size reestimation with count data: Methods and applications in multiple sclerosis (2010) (57)
Aspects of Modernizing Drug Development Using Clinical Scenario Planning and Evaluation (2010) (54)
Evaluation of dysphagia by novel real-time MRI (2016) (54)
Sample size recalculation for binary data in internal pilot study designs (2004) (54)
A Comparison of Methods for Adaptive Treatment Selection (2008) (54)
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries (2017) (53)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis (2016) (52)
Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design (2011) (52)
On the inappropriateness of an EM algorithm based procedure for blinded sample size re‐estimation (2002) (51)
Random‐effects meta‐analysis of few studies involving rare events (2018) (51)
Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis (2018) (50)
Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis (2018) (50)
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis (2011) (50)
Assessment of statistical significance and clinical relevance (2013) (49)
Planning and analysis of three‐arm non‐inferiority trials with binary endpoints (2007) (49)
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis (2020) (49)
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2011) (49)
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis (2019) (48)
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome (2016) (48)
Adhesion Maturation of Neutrophils on Nanoscopically Presented Platelet Glycoprotein Ibα (2013) (44)
Validation and Reliability of the Neuropathic Pain Scale (NPS) in Multiple Sclerosis (2007) (43)
Longitudinal assessment of multiple sclerosis with the brain-age paradigm. (2020) (43)
Blinded Sample Size Reestimation with Negative Binomial Counts in Superiority and Non-inferiority Trials (2010) (42)
Blinded sample size reassessment in non‐inferiority and equivalence trials (2003) (42)
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) (42)
Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study (2019) (42)
Systematic Review of Randomized Controlled Trials of Clinical Prediction Rules for Physical Therapy in Low Back Pain (2013) (41)
On weakly informative prior distributions for the heterogeneity parameter in Bayesian random‐effects meta‐analysis (2020) (41)
On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies (2018) (39)
Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. (2010) (37)
Development of oral immunomodulatory agents in the management of multiple sclerosis (2011) (37)
Interleukin‐2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta‐analysis of controlled studies (2014) (37)
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease (2013) (36)
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register (2020) (36)
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations (2017) (35)
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue? (2020) (35)
Calcineurin Inhibitor Sparing With Mycophenolate Mofetil in Liver Transplantion: A Systematic Review of Randomized Controlled Trials (2012) (35)
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19 (2020) (34)
Echocardiographic Estimation of Mean Pulmonary Artery Pressure: A Comparison of Different Approaches to Assign the Likelihood of Pulmonary Hypertension (2018) (34)
Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes (2011) (32)
Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis (2011) (32)
Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial. (2020) (31)
Blinded sample size re‐estimation in superiority and noninferiority trials: bias versus variance in variance estimation (2013) (30)
Back schools for the treatment of chronic low back pain: possibility of benefit but no convincing evidence after 47 years of research—systematic review and meta-analysis (2016) (30)
Power and sample size determination when assessing the clinical relevance of trial results by ‘responder analyses’ (2004) (29)
Recent advances in methodology for clinical trials in small populations: the InSPiRe project (2018) (29)
Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators (2015) (28)
Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice. (2014) (28)
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression (2013) (28)
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care (2014) (28)
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: A systematic review and meta-analysis (2012) (28)
Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis (2014) (28)
Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. (2018) (27)
Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) – a double-blind, randomized, controlled comparative effectiveness trial (2018) (27)
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results (2020) (27)
Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis (2016) (26)
Primum non nocere: shared informed decision making in low back pain – a pilot cluster randomised trial (2014) (26)
Practice nursed-based, individual and video-assisted patient education in oral anticoagulation - Protocol of a cluster-randomized controlled trial (2011) (26)
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets – a primer for academic researchers (2016) (25)
Discrete Approximation of a Mixture Distribution via Restricted Divergence (2016) (25)
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS (2012) (25)
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
A design‐by‐treatment interaction model for network meta‐analysis and meta‐regression with integrated nested Laplace approximations (2018) (24)
Blinded Sample Size Reestimation in Multiarmed Clinical Trials (2000) (24)
Dynamically borrowing strength from another study through shrinkage estimation (2018) (24)
Toward evidence‐based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform (2017) (24)
A Comparison of Peritonitis in Polycystic and Non-Polycystic Patients on Peritoneal Dialysis (2004) (24)
Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial (2021) (23)
An R package for implementing simulations for seamless phase II/III clinical trials using early outcomes for treatment selection (2012) (23)
Model averaging for robust extrapolation in evidence synthesis (2018) (23)
Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis (2010) (23)
Economic Analysis of a Telemedicine Intervention to Improve Glycemic Control in Patients with Diabetes Mellitus (2006) (23)
Systematic review of sonographic chronic cerebrospinal venous insufficiency findings in multiple sclerosis (2011) (22)
Exploring changes in treatment effects across design stages in adaptive trials (2009) (22)
Blinded Sample Size Reestimation in Non‐Inferiority Trials with Binary Endpoints (2007) (22)
Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy. (2018) (21)
A Bootstrap Procedure for Adaptive Selection of the Test Statistic in Flexible Two‐Stage Designs (2002) (20)
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R (2020) (20)
A Comparison of Methods for Treatment Selection in Seamless Phase II/III Clinical Trials Incorporating Information on Short-Term Endpoints (2015) (20)
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis – an observational study (2015) (19)
Bladder symptoms in multiple sclerosis: a review of pathophysiology and management (2010) (19)
Employment-associated factors in multiple sclerosis: Results of a cross-sectional study in Germany (2016) (19)
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial) (2017) (19)
Blinded sample size re‐estimation in crossover bioequivalence trials (2014) (19)
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases (2017) (19)
Rationale and design of the EU‐CERT‐ICD prospective study: comparative effectiveness of prophylactic ICD implantation (2018) (18)
Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype (2011) (18)
Identifying back pain subgroups: developing and applying approachesusing individual patient data collected within clinical trials (2016) (18)
Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials (2017) (18)
Biometrical Journal and Reproducible Research (2009) (18)
Robustness of testing procedures for confirmatory subpopulation analyses based on a continuous biomarker (2018) (18)
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry (2021) (18)
Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29 (2017) (17)
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data (2014) (17)
Accelerated brain ageing and disability in multiple sclerosis (2019) (17)
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis (2017) (17)
Heart failure with preserved ejection fraction according to the HFA‐PEFF score in COVID‐19 patients: clinical correlates and echocardiographic findings (2021) (17)
Memorandum “Open Metadata” (2015) (16)
Using phase II data for the analysis of phase III studies: An application in rare diseases (2016) (16)
Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic Cardiomyopathy. (2016) (16)
Perspectives on the Use of Adaptive Designs in Clinical Trials. Part II. Panel Discussion (2010) (16)
Blinded continuous monitoring of nuisance parameters in clinical trials (2012) (16)
Optimal choice of the number of treatments to be included in a clinical trial (2009) (16)
WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis. (2015) (15)
A studentized permutation test for three‐arm trials in the ‘gold standard’ design (2016) (15)
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression (2013) (15)
Exercise training in patients with a left ventricular assist device (Ex‐VAD): rationale and design of a multicentre, prospective, assessor‐blinded, randomized, controlled trial (2019) (15)
Design and analysis of three‐arm trials with negative binomially distributed endpoints (2016) (15)
Robustness of methods for blinded sample size re‐estimation with overdispersed count data (2013) (15)
Is there a role for statistics in artificial intelligence? (2020) (14)
Insights into permanent pacemaker implantation following TAVR in a real-world cohort (2018) (14)
Scientific Versus Experiential Evidence: Discourse Analysis of the Chronic Cerebrospinal Venous Insufficiency Debate in a Multiple Sclerosis Forum (2015) (14)
A Note on Change Point Estimation in Dose-Response Trials (2001) (14)
Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study (2019) (14)
Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies (2018) (14)
Sample size calculation in multi-centre clinical trials (2018) (14)
Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendations (2021) (14)
Design and semiparametric analysis of non‐inferiority trials with active and placebo control for censored time‐to‐event data (2013) (14)
Blinded sample size re‐estimation for recurrent event data with time trends (2013) (14)
A Bayesian time‐to‐event pharmacokinetic model for phase I dose‐escalation trials with multiple schedules (2020) (13)
A Comparison of Procedures for Adaptive Choice of Location Tests in Flexible Two‐Stage Designs (2003) (13)
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS? (2015) (13)
Software tools for implementing simulation studies in adaptive seamless designs: introducing R package ASD (2011) (13)
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death (2021) (12)
Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression (2019) (12)
Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction (2018) (12)
Design and Development of a Decision Support Package for Low Back Pain (2014) (12)
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions (2016) (12)
Impact of community neonatal services: a multicentre survey (2002) (12)
Blinded and unblinded internal pilot study designs for clinical trials with count data (2013) (12)
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial (2020) (12)
Blinded sample size reestimation in event‐driven clinical trials: Methods and an application in multiple sclerosis (2019) (11)
Modelling and sample size reestimation for longitudinal count data with incomplete follow up (2019) (11)
Group sequential designs for negative binomial outcomes (2017) (11)
Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients—A systematic review and meta-analysis (2017) (11)
Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction (2021) (11)
Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease. (2014) (11)
Sample size re‐estimation for clinical trials with longitudinal negative binomial counts including time trends (2018) (11)
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations (2019) (11)
Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial (2015) (10)
Considerations on what constitutes a ‘qualified statistician’ in regulatory guidelines (2012) (10)
Study protocol: Improving patient choice in treating low back pain (IMPACT - LBP): A randomised controlled trial of a decision support package for use in physical therapy (2011) (10)
Causal inference methods for small non-randomized studies: Methods and an application in COVID-19 (2020) (10)
Blinded sample size re‐estimation in three‐arm trials with ‘gold standard’ design (2016) (10)
Sample Size Reassessment in Non-inferiority Trials (2010) (10)
A systematic review and meta‐analysis of published cases reveals the natural disease history in multiple sulfatase deficiency (2020) (10)
Estimating and comparing adverse event probabilities in the presence of varying follow‐up times and competing events (2020) (10)
Blinded continuous monitoring in clinical trials with recurrent event endpoints (2018) (10)
CR1 is potentially associated with rate of decline in sporadic Alzheimer’s disease (2014) (10)
Blinded assessment of treatment effects utilizing information about the randomization block length (2009) (9)
Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks. (2020) (9)
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study (2020) (9)
Antibody signatures in patients with histopathologically defined multiple sclerosis patterns (2020) (9)
Blinded Sample Size Recalculation in Noninferiority Trials: A Case Study in Dermatology (2010) (9)
Bounds for the weight of external data in shrinkage estimation (2020) (9)
Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data (2013) (8)
Adaptive trial designs in diagnostic accuracy research (2019) (8)
Herbal treatment with Uva Ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial. (2021) (8)
A conditional error function approach for adaptive enrichment designs with continuous endpoints (2019) (8)
Effects of strategies to improve general practitioner-nurse collaboration and communication in regard to hospital admissions of nursing home residents (interprof ACT): study protocol for a cluster randomised controlled trial (2020) (8)
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency (2022) (8)
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]. (2020) (8)
Peripheral Nerve Dysfunction in Middle-Aged Subjects Born with Thalidomide Embryopathy (2016) (8)
Spline-based procedures for dose-finding studies with active control (2014) (8)
Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators (2019) (8)
Sample Size Adjustment in Clinical Trials for Proving Equivalence (2001) (8)
T-wave loop area from a pre-implant 12-lead ECG is associated with appropriate ICD shocks (2017) (8)
A systematic review identifies shortcomings in the reporting of crossover trials in chronic painful conditions. (2015) (8)
A Note on Testing for Intervention Effects on Binary Responses (2006) (7)
Intervention effects in observational survival studies with an application in total hip replacements (2003) (7)
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosis. (2018) (7)
Data monitoring committees for clinical trials evaluating treatments of COVID-19 (2020) (7)
Considerations in the design of clinical trials for relapsing multiple sclerosis (2012) (7)
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression (2022) (7)
Sample Size Re-Estimation (2021) (6)
P309 BLOOD PRESSURE PROFILE OF LUMIRACOXIB IS SIMILAR TO PLACEBO IN ARTHRITIS PATIENTS (2006) (6)
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials (2018) (6)
Random-effects meta-analysis of Phase I dose-finding studies using stochastic process priors (2019) (5)
Factors Influencing the Frequency of Airway Infections in Underage Refugees: A Retrospective, Cross Sectional Study (2020) (5)
Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) (2014) (5)
The impact of smoking cessation on multiple sclerosis disease progression (2021) (5)
Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control (2014) (5)
Planning and analysis of three‐arm non‐inferiority trials with binary endpoints (2010) (5)
Group sequential designs with robust semiparametric recurrent event models (2018) (5)
On the role of data, statistics and decisions in a pandemic (2021) (5)
Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations (2016) (5)
The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease (2016) (5)
Sample size re‐estimation incorporating prior information on a nuisance parameter (2017) (5)
Strategies to reduce antibiotic use in women with uncomplicated urinary tract infection in primary care: protocol of a systematic review and meta-analysis including individual patient data (2020) (5)
dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials (2018) (5)
RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress Trial. (2022) (5)
Title Correction: Sources of Information and Behavioral Patterns in Online Health Forums: Observational Study (2014) (5)
Phase I dose-escalation oncology trials with sequential multiple schedules (2021) (5)
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks (2020) (5)
Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. (2019) (5)
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials (2020) (5)
Modeling the Recovery from Depressive Illness by an Exponential Model with Mixed Effects (2000) (5)
Do we consent to rules of consent and confidentiality? (2017) (4)
Efficiency of adaptive designs (2010) (4)
Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events (2020) (4)
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]. (2020) (4)
Blinded sample size reestimation for negative binomial regression with baseline adjustment (2020) (4)
Correction: ‘A conditional error function approach for subgroup selection in adaptive clinical trials’ (2013) (4)
Identification of subgroup effect with an individual participant data meta-analysis of randomised controlled trials of three different types of therapist-delivered care in low back pain (2021) (4)
Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials (2019) (4)
Influence of individual, illness and environmental factors on place of death among people with neurodegenerative diseases: a retrospective, observational, comparative cohort study (2021) (4)
Correction: study protocol: improving patient choice in treating Low back pain (IMPACT - LBP): a randomised controlled trial of a decision support package for use in physical therapy (2011) (4)
Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis (2014) (4)
Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks. (2020) (4)
Plasma prion protein concentration and progression of Alzheimer disease (2014) (4)
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE‐FMR trial (2021) (4)
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial (2021) (4)
Dynamically borrowing strength from another study (2018) (4)
Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease. (2015) (4)
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies. (2022) (3)
Risk stratification of ICD patients for appropriate shock and mortality in a multi-centre cohort. The EU-TrigTreat study (2015) (3)
Study protocol for a randomised controlled trial of a web-based behavioural lifestyle programme for emPOWERment in early Multiple Sclerosis (POWER@MS1) (2021) (3)
Double arcsine transform not appropriate for meta‐analysis (2022) (3)
Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems (2020) (3)
Clinical Scenario Evaluation - A Framework for Evaluating Competing Development Strategies (2009) (3)
Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency (2022) (3)
Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure (2022) (3)
Electrocardiogram as a predictor of survival without appropriate shocks in primary prophylactic ICD patients: A retrospective multi-center study. (2020) (3)
Noninferiority trials: What's clinically (ir)relevant? (2020) (3)
Precise variant interpretation, phenotype ascertainment, and genotype–phenotype correlation of children in the EARLY PRO‐TECT Alport trial (2020) (3)
A potential for seamless designs in diagnostic research could be identified. (2020) (3)
Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data (2020) (3)
Contribution to the discussion of “When should meta‐analysis avoid making hidden normality assumptions?” A Bayesian perspective (2018) (3)
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2022) (3)
Overview of the programme (2016) (2)
Blinded Sample Size Reestimation (2008) (2)
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression (2022) (2)
Blinded sample size reestimation with count data (2010) (2)
multiple sclerosis : A systematic review and meta-analysis Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing (2012) (2)
Clinical trial design: statistical issues (2018) (2)
A loss-function based approach for dose selection in two-stage dose-response trials. (2001) (2)
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study (2020) (2)
Managing neuropsychological impairment in multiple sclerosis - Controlled study on a standardized metacognitive intervention (MaTiMS). (2022) (2)
A dose finding design for seizure reduction in neonates (2019) (2)
Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993–2018 (2020) (2)
Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study (2021) (2)
Effect of Carillon Mitral Contour System on patient‐reported outcomes in functional mitral regurgitation: an individual participant data meta‐analysis (2021) (2)
Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules (2020) (2)
MetaStan: An R package for Bayesian (model-based) meta-analysis using Stan (2022) (2)
Seamless phase II/III clinical trials using early outcomes for treatment or subgroup selection: Methods and aspects of their implementation (2019) (2)
Phase I dose-escalation trials with more than one dosing regimen (2018) (2)
Exact change point detection with improved power in small‐sample binomial sequences (2020) (2)
Venom protection by antibody from a snakebite hyperimmune subject (2022) (2)
Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement. (2021) (2)
Direct proteomic and high-resolution microscopy biopsy analysis identifies distinct ventricular fates in severe aortic stenosis. (2022) (2)
A confidence interval robust to publication bias for random‐effects meta‐analysis of few studies (2020) (2)
Blinded sample size recalculation in adaptive enrichment designs (2022) (2)
Adjusting for publication bias in meta-analysis via inverse probability weighting using clinical trial registries. (2021) (2)
Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency. (2022) (2)
An Unconditional Test for Change Point Detection in Binary Sequences with Applications to Clinical Registries (2016) (2)
Discussion on the meeting on ‘Signs and sizes:understanding and replicating statistical findings’ (2019) (2)
Data on differential multivariable risk prediction of appropriate shock vs. competing mortality (2018) (2)
Improving the statistical power of economic experiments using adaptive designs (2022) (2)
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project. (2019) (2)
First international meeting of early career investigators: Current opportunities, challenges and horizon in critical care nutrition research. (2020) (1)
Sample data sharing agreement (2016) (1)
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression (2021) (1)
Subgroup identification in individual participant data meta-analysis using model-based recursive partitioning (2020) (1)
Robust Confidence Intervals for Meta-Regression with Interaction Effects (2022) (1)
Semi‐parametric analysis of overdispersed count and metric data with varying follow‐up times: Asymptotic theory and small sample approximations (2018) (1)
Herbal Treatment with Uva Ursi Extract versus Fosfomycin for Women with Uncomplicated Urinary Tract Infection: A Double-Blind, Randomised, Controlled Comparative Effectiveness Phase 4 Trial (REGATTA) (2020) (1)
Applications of AI / ML approaches in cardiovascular medicine : A systematic review 1 with recommendations 2 (2021) (1)
Blinded sample size re-calculation in multiple composite population designs with normal data and baseline adjustments (2020) (1)
Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis. (2022) (1)
Evaluation of a patient-centred biopsychoSocial blended collaborative CAre Pathway for the treatment of multi-morbid Elderly patients – The ESCAPE clinical study (2022) (1)
Implementation, mechanisms of change and contextual factors of a complex intervention to improve interprofessional collaboration and the quality of medical care for nursing home residents: study protocol of the process evaluation of the interprof ACT intervention package (2022) (1)
The theory of response‐adaptive randomization in clinical trials. Feifang Hu and William F. Rosenberger, Wiley, Hoboken, NJ, 2006. No. of pages: xiii +232. Price: $96.00. ISBN13: 978‐0‐471‐65396‐7 (2008) (1)
SKETCHING BEHAVIOUR IN OBJECT RECALL AND OBJECT COPYING. (2004) (1)
Improving the Power of Economic Experiments Using Adaptive Designs (2021) (1)
Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions (2022) (1)
Safety and Feasibility of G-CSF Compassionate use in ALS Patients (P6.009) (2015) (1)
Regularization approaches in clinical biostatistics: A review of methods and their applications (2022) (1)
The impact of neglected confounding and interactions in mixed-effects meta-regression (2023) (1)
Reduced Clostridioides difficile infections in hospitalised older people through multiple quality improvement strategies. (2021) (1)
A straightforward meta‐analysis approach for oncology phase I dose‐finding studies (2021) (1)
[Multifocal ERG with confocal scanning laser ophthalmoscope. Comparison with monitor simulation]. (2002) (1)
Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis. (2022) (1)
Repeating noninvasive risk stratification improves prediction of outcome in ICD patients (2020) (1)
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY) -- comparison of adverse event risks in randomized controlled trials (2020) (1)
A machine learning algorithm for electrocardiographic fQRS quantification validated on multi-center data (2022) (1)
Crosswalking between disability questionnaire scores (2016) (1)
Sample size calculation for the augmented logrank test in randomized clinical trials (2022) (1)
Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial (2021) (1)
Clinical trials in oncology (2008) (1)
QRS micro-fragmentation as a mortality predictor (2022) (1)
Efficacy of Ambroxol lozenges for pharyngitis: a (2014) (1)
A Bayesian Time-to-event Pharmacokinetic Model for Sequential Phase I Dose-escalation Trials with Multiple Schedules (2020) (1)
Role of the proportion of sudden cardiac death to mortality for clinical effectiveness of primary prevention ICDs. (2020) (1)
A Review of: “Selection Bias and Covariate Imbalances in Randomized Clinical Trials, by V. W. Berger” (2006) (1)
Effect of the left internal mammary artery to the left anterior descending artery on mortality and morbidity after combined coronary and valve operations. (2005) (1)
Improving adaptive seamless designs through Bayesian optimization (2021) (1)
Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study (2020) (1)
Using clinical trial registries to inform Copas selection model for publication bias in meta‐analysis (2020) (1)
Cluster randomised trial of a complex interprofessional intervention (interprof ACT) to reduce hospital admission of nursing home residents (2023) (1)
A fully automated online fatigue management program for patients with 1 multiple sclerosis: A randomized controlled trial 2 (2018) (0)
QRS duration as an independent risk factor for appropriate shocks and mortality in patients with prophylactic implantable cardioverter-defibrillator (2022) (0)
Cost-Effectiveness of Inter-Professional Collaboration to Reduce Hospitalisations in Nursing Home Residents: Results from the German Interprof ACT Trial (2023) (0)
Interventions to Promote Female Economic Empowerment in Low- and Middle-income Countries: A Systematic Review of Reforms to Labor Market, Land, Inheritance and Participation of Women in Decision Making (2016) (0)
P1223Prediction model for shock risk and mortality in ICD patients (2018) (0)
Confidence intervals for discrete data in clinical research by VivekPradhan, Ashis K.Gangopadhyay, Sandeep M.Menon, CynthiaBasu, TathagataBanerjee.Boca Raton, FL: Chapman & Hall/CRC Press. 2022. 240 pages. ISBN: 9781138048980 (hbk). ISBN 9781315169859 (ebk). List price: £99.99 (2023) (0)
Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection (2021) (0)
Authors’ response: on the role of data, statistics and decisions in a pandemic (2022) (0)
Evaluating an app for digital medical history taking in urgent care practices: study protocol of the cluster-randomized interventional trial ‘DASI’ (2023) (0)
Contrasting natural history and therapy-induced effects on disability outcomes: a systematic review of randomized, placebo controlled trials in relapsing multiple sclerosis (2013) (0)
A NON-LINEAR HIERARCHICAL MODEL FOR EVIDENCE SYNTHESIS OF SAFETY DATA (2007) (0)
Apheresis in the treatment of an acute attack of a demyelinating central nervous system disorder (2013) (0)
Developing Simulation Tools in R for Planning Adaptive Seamless Designs: An Application in Multiple Sclerosis (2009) (0)
P3451Electrocardiogram as a predictor of survival without appropriate shocks in primary prophylactic ICD patients: a retrospective multi-center study (2018) (0)
P2876Repeating non-invasive risk stratification tests improves the prediction of outcomes of ICD patients in the EUTrigTreat study (2019) (0)
Model-based recursive partitioning for discrete event times (2022) (0)
Using the bayesmeta R package for Bayesian random-effects meta-regression (2022) (0)
Analysis of over-dispersed count data with varying follow-up times : Asymptotic theory and small sample approximations (2018) (0)
Methodology and statistical developments 4: subgroup identification with individual participant data indirect network meta-analysis (2016) (0)
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study. (2023) (0)
Adaptive Designs: What are they and why do we need them? (2008) (0)
Improved description of clinical features of multiple sulfatase deficiency: A meta-analysis of published cases (2019) (0)
Sample size re-estimation and continuous monitoring of the variance in longitudinal trials (2014) (0)
Review 2: summary of excluded papers (2016) (0)
Accounting for Time Dependency in Meta-Analyses of Concordance Probability Estimates (2022) (0)
Adaptive Clinical Trials Incorporating Treatment Selection and Evaluation : Methodology and Applications in Multiple Sclerosis (2009) (0)
Effectiveness of a specialist palliative home care nurse–patient consultation followed by an interprofessional telephone case conference compared with usual care among patients with non-oncological palliative care needs: protocol for the multicentre KOPAL cluster-randomised controlled trial (2022) (0)
Adaptive clinical trial design for treatment selection and evaluation in multiple sclerosis (MS-Adaptive) (2009) (0)
Searching for cost-effective subgroups : application of an adaptive search algorithm to individual patient data from a trial of physical therapies for low back pain (2014) (0)
Efficacy of immunotherapies and predictors of therapy response in neuromyelitis optica spectrum disorders: analysis of 397 treatment years from 150 patients (2016) (0)
Design and analysis of clinical trials: Concepts and methodologies (second edition) Chow S-C, Liu J-P (2004)ISBN 0471249858; 752 pages; 76.50; ??108.40; $130.00 Wiley; (2004) (0)
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies. (2023) (0)
Development and Validation of a Multivariable Risk Prediction Model for Sudden Cardiac Death after Myocardial Infarction (PROFID Risk Model): Study Rationale, Design and Protocol (2021) (0)
Patient-Centered Approach Might Effectively Tackle The Definition Of Progression In Chronic Neurological Diseases: Results From the EmBioProMS Trial in Progressive Multiple Sclerosis. (2021) (0)
Developing a new trial design in secondary progressive multiple sclerosis: a seamless adaptive approach (2009) (0)
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol (2022) (0)
Novel MRI methodology: real-time assessment of swallowing in inclusion body myositis (IBM) (2015) (0)
Ju l 2 01 7 Group sequential designs for negative binomial outcomes (2018) (0)
Blind sample size adjustment in clinical trials: a case study. (2001) (0)
Quantitative approaches underpinning decision making (2019) (0)
Subgroup identification in individual participant data meta-analysis using model-based recursive partitioning (2021) (0)
Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS) (2350) (2020) (0)
Nuisance parameter based sample size re-estimation incorporating prior information (2017) (0)
Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report (2022) (0)
IMPROVING PATIENT CHOICE IN TREATING LOW BACK PAIN (IMPACT-LBP): RESULTS FROM A RANDOMISED CONTROL TRIAL (2014) (0)
Methodology and statistical developments 3: identification of cost-effective subgroups by directed peeling (2016) (0)
Approximate sample size formulas for one-way analysis of variance. (2000) (0)
How does T-wave alternans correlate with other clinical parameters including those reflecting autonomic tone? An interim analysis form the EUTrigTreat clinical study (2012) (0)
Statistics and Life Sciences 2008 – First Conference of the Central European Network of the International Biometric Society (2009) (0)
Adaptive Designs and Multiple Testing Procedures Workshop 2021: June 10th – 11th (2021) (0)
Calcineurin Inhibitor Sparing with Mycophenolate Mofetil in Liver Transplant Recipients: A Systematic Review and Meta-Analysis: 523 (2012) (0)
The influence of gender, age and hyperglycaemic state on mortality in central Lancashire (2002) (0)
Methodology and statistical developments 2: subgroup identification using an adaptive refinement by directed peeling algorithm (2016) (0)
Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysis (2022) (0)
Reproducibility of repetitive T-wave alternans measurements in the EUTrigTreat study (2015) (0)
Methodology and statistical developments 1: subgroup identification with recursive partitioning (2016) (0)
153-01: Repeated assessment of non-invasive risk stratification in the EUTrigTreat study (2016) (0)
Adaptive clinical trials incorporating treatment selection and evaluation: methodology and application in progressive multiple sclerosis. (2009) (0)
Validation of a Prospective Urinalysis-Based Prediction Model for the Outcome of COVID-19 Disease: A Multicenter Cohort Study (2020) (0)
Erratum: Study protocol: Improving patient choice in treating Low back pain (IMPACT - LBP): A randomised controlled trial of a decision support package for use in physical therapy (BMC Musculoskeletal Disorders (2013) 14 (158)) (2013) (0)
Statistics in Regulatory Affairs in www.wikipedia.org: Initiative of the ISCB Statistics in Regulatory Affairs Subcommittee (SiRA SC) (2016) (0)
OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial (2019) (0)
OC035—Self-Empowering Patients—A Promising Example In Oral Anticoagulation (2013) (0)
Guest Editors' Introduction (2014) (0)
Information Flows in Patient-Oriented Online Media and Scientific Research (2017) (0)
Combination Test Approach, Single Stage Tests, and Adaptive Dunnett Test (2008) (0)
Trochleoplasty versus MPFL-Reconstruction in Severe Trochlear Dysplasia. A Systematic Review and Meta-Analysis (2016) (0)
The potential of adaptive designs. (2001) (0)
Trials of Novel Therapies Specifically for Progressive MS (2018) (0)
P2915Multivariable risk prediction of appropriate shock and mortality in ICD patients (2018) (0)
EDSS progression in placebo cohorts in relapsing MS : A systematic review and meta-regression (2015) (0)
Contents: Biometrical Journal 2'17. (2017) (0)
Editorial Board: Biometrical Journal 6'15 (2015) (0)
Effect of Intravenous Iron Replacement on Recurrent Heart Failure Hospitalizations and Cardiovascular Mortality in Patients with Heart Failure and Iron Deficiency: A Bayesian Meta-Analysis. (2023) (0)
7 Incorporating pharmacokinetic information in phase I studies in small populations (2015) (0)
Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis (2023) (0)
Ferric Carboxymaltose in Iron Deficient Patients Admitted for Acute Heart Failure (2020) (0)
T-wave alternans poorly prognostic in primary prophylactic ICD patients: a prospective EU-CERT-ICD study (2022) (0)
Comparison of disability and relapse outcomes in randomised, placebo controlled trials in relapsing multiple sclerosis: A systematic review and meta-regression (2013) (0)
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial (2022) (0)
A simple meta-analysis approach for exploratory phase I dose-finding studies (2021) (0)
REAL-TIME CMR IMAGING FOR NON-INVASIVE CHARACTERISATION OF HFPEF: MEDIUM-TERM OUTCOMES OF THE HFPEF STRESS TRIAL (2022) (0)
Contents: Biometrical Journal 3'21 (2020) (0)
Author's response to reviews Title:A modified Wald interval for the area under the ROC curve (AUC) in diagnostic case-control studies Authors: (2013) (0)
Guidances for statistics in regulatory affairs in Wikipedia: Initiative of the ISCB Statistics in Regulatory Affairs Subcommittee (SiRA SC) (2017) (0)
Creating the repository database and data control (2016) (0)
Comparison of adverse event risks in randomized controlled trials with varying follow-up times and competing events: Results from an empirical study (2022) (0)
Acute respiratory infections in an adult refugee population: an observational study (2021) (0)
Modified Knapp-Hartung random-effects meta-analysis recommended for applications in rare diseases (2015) (0)
Development and Validation of Explainable Machine Learning Models for Risk of Mortality in TAVI - TRIM Scores (2023) (0)
Instruction on secure data transfer (2016) (0)
On the role of benchmarking data sets and simulations in method comparison studies. (2022) (0)
Sex-Related Differences in T2 Lesion Load in Pediatric Multiple Sclerosis Patients (2016) (0)
Preliminary statistical analyses and results (2016) (0)
Adaptive Design Methods in Clinical Trials by S.-C. Chow and M. Chang (2008) (0)
FP36-WE-01 Adaptive seamless trial designs in neurology: a case study in secondary progressive multiple sclerosis (2009) (0)
P1689Prognostic significance of different patterns and amplitude of QRS fragmentation in patients with implantable defibrillator in primary prevention (2017) (0)
Scatterplots of raw change scores of outcome measures (2016) (0)
Use of the INSIGHT detection algorithm in subcutaneous ICDs in pacemaker patients Prognostic signiﬁcance of different patterns and amplitude of QRS fragmentation in patients with implantable deﬁbrillator in primary prevention heart in ICD patients: a useless tool? (0)
Treatment of neuropathic pain for multiple sclerosis (2001) (0)
Authors' Reply (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tim Friede?

Tim Friede is affiliated with the following schools:

Tim Friede's Academic­Influence.com Rankings

Tim Friede's Degrees

Similar Degrees You Can Earn

Why Is Tim Friede Influential?

Tim Friede's Published Works

Published Works

What Schools Are Affiliated With Tim Friede?

Tim Friede's AcademicInfluence.com Rankings